Kindred Biosciences (KIN) Tops Q3 EPS by 5c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. MA
9. FND
10. DASH

Go back to Kindred Biosciences (KIN) Tops Q3 EPS by 5c

Kindred Biosciences Announces Third Quarter 2016 Financial Results

November 7, 2016 9:01 AM EST

SAN FRANCISCO, Nov. 7, 2016 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced financial results for the third quarter ended September 30, 2016 and provided updates on its programs.

"We are pleased with the progress across our programs as we execute our strategy of quickly and cost-effectively developing therapeutics for our animal family members. In support of the anticipated launch of Zimeta (dipyrone injection) and Mirataz (mirtazapine 2% ointment), we have been hiring key... More